nCoV Map

COVID-19 vaccine approved for children six months and older
United Kingdom // 06 December, 2022
Recommendation by the Joint Committee on Vaccination and Immunisation still pending...
COVID-19
Bebtelovimab, COVID-19 treatment no longer authorised by FDA
United States // 30 November, 2022
It is not expected to be effective against new dominants subvariants...
COVID-19
WHO COVID-19 weekly reports November 2022
30 November, 2022
WHO updates on the global COVID-19 situation continue to show...
COVID-19
Vaccine effectiveness against Omicron variant, WHO
24 November, 2022
Evidence based on 53 studies...
COVID-19
Bivalent vaccines protect against symptomatic COVID-19 infection
United States // 22 November, 2022
First published investigations of vaccine effectiveness for new bivalent mRNA booster...
COVID-19
First domestically created oral COVID-19 drug
Japan // 22 November, 2022
About one million doses will be sold to the government...
COVID-19
Vaccine update - Administration of fourth dose has begun
Angola // 22 November, 2022
Fourth dose of COVID-19 vaccine starts...
COVID-19
EMA authorises VidPrevtyn Beta COVID-19 vaccine, updates Spikevax clinical data
18 November, 2022
Both vaccines have been approved for use...
COVID-19
COVID-19 cases rise
Brazil // 18 November, 2022
A rise in COVID-19 cases due to Omicron sub-variants BQ.1 and XBB ...
COVID-19
Omicron variant BA.2 more likely to elicit symptoms
United Kingdom // 15 November, 2022
Study of over 1.5 million people…
COVID-19
COVID-19 Vaccine Update – ATAGI updated recommendations on Pfizer bivalent booster dose in 18 years and older
Australia // 15 November, 2022
Updated recommendations for aged 18 years and above...
COVID-19
COVID-19 variants- Cases of BN.1 increasing, BQ.1.1 and BQ.1 are now predominant
United States // 14 November, 2022
BA.5 cases are decreasing...
COVID-19
Moderna bivalent booster elicits higher antibody response
United States // 14 November, 2022
Antibody response against rising variant of concern...
COVID-19
COVID-19 Vaccine Update - Pfizer's BA.4/BA.5 bivalent vaccine to be used
South Korea // 14 November, 2022
Will be available from 14 November for people 18 and older...
COVID-19
FDA authorises Kineret for the treatment of COVID-19
United States // 09 November, 2022
For use in hospitalised patients...
COVID-19
Novavax booster and Pfizer/BioNTech bivalent vaccine receive approval from MHRA
United Kingdom // 09 November, 2022
Additional booster vaccines granted authorization...
COVID-19
Increase in COVID-19 cases caused by new Omicron subvariant XBB
Australia // 09 November, 2022
Health authorities have reported a rise in COVID-19 case numbers...
COVID-19
ECDC interim analysis of ongoing COVID-19 vaccine effectiveness study
08 November, 2022
Ages 20-29 included for the first time...
COVID-19
Study in mice shows that pazopanib has potential to treat COVID-19 patients
08 November, 2022
FDA approved anticancer drug improved acute lung injury...
COVID-19
ECDC Weekly COVID-19 report shows decreasing trend
04 November, 2022
Rates of cases and deaths continue to decrease but more detections of BQ.1 point to expected higher activity in the coming weeks...
COVID-19

Quick Links

nCoV Map

LATEST NEWS (PREMIUM ACCESS)